FYX 051 Good Manufacturer supply High Quality 577778-58-6
- Molecular Formula:C13H8N6
- Molecular Weight:248.247
- Boiling Point:594.7±60.0 °C(Predicted)
- PKA:7.47±0.10(Predicted)
- PSA：91.14000
- Density:1.45±0.1 g/cm3(Predicted)
- LogP:1.80038
FYX 051 (577778-58-6) Usage
Topiroxostat is an orally-administered, non-purine, selective xanthine oxidase (XO) inhibitor developed for the treatment of hyperuricemia specifically for patients with gout in Japan. The drug was discovered and developed by Fuji Yakuhin. In contrast to conventional XO inhibitors such as febuxostat, topiroxostat interacts with key amino acid residues of the solvent channel.
How to get the best price on FYX 051?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of FYX 051 . You can buy high quality, low price FYX 051 577778-58-6 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
